Xin Wang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Cross Sectional

Breast Cancer Risk

Radiation Induced

Top Venues

Cancer communications (London, England)

Clinical and translational medicine

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jiaxuan Liu, Maiyue He, Kaiping Ou, Xin Wang, Yipeng Wang, Liqiang Qi, Yue Chai, Mingxia Jiang, Zongbi Yi, Yang Luo, Peng Yuan, Pin Zhang, Binghe Xu, Qiao Li
Efficacy and safety of apatinib combined with dose-dense paclitaxel and carboplatin in neoadjuvant therapy for locally advanced triple-negative breast cancer: A prospective cohort study with propensity-matched analysis. International journal of cancer (2023)
Wei Liu, Yi Zeng, Xinhui Hao, Xin Wang, Jiaxiang Liu, Tianyang Gao, Mengdi Wang, Jingyao Zhang, Miaomiao Huo, Ting Hu, Tianyu Ma, Die Zhang, Xu Teng, Hefen Yu, Min Zhang, Baowen Yuan, Wei Huang, Yunkai Yang, Yan Wang
JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte-derived leptin. Cancer communications (London, England) (2023)
Xin Wang, Kexin Feng, Wenyan Wang, Xiangzhi Meng, Jiaqi Liu, Yang Yang, Yuting Zhong, Jingruo Li, Shikai Wu, Minghui Li, Pan Ma, Qinfu Feng, Hongmei Zeng, Yuanting Gu, Xiru Li, Zhaoqing Fan, Xiang Wang
Long-term outcomes of intraoperative radiotherapy for early-stage breast cancer in China: a multicenter real-world study. Cancer communications (London, England) 42 (3) (2022)
Chenxuan Yang, Jiaxiang Liu, Shuangtao Zhao, Jianming Ying, Yueping Liu, Li Ma, Qingyao Shang, Xiangzhi Meng, Kexin Feng, Bo Zheng, Changyuan Guo, Xin Wang, Xiang Wang
Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk-group classification in luminal-B breast cancer. Clinical and translational medicine 11 (11) (2022)